In a recent study conducted for Pilgrim, quality and compliance professionals from the top 2,000 Pharmaceutical, BioTech, Medical Device, and Combination Product companies were surveyed on the “state of the state” of the business, regulatory, and technology landscape of their current quality management systems (QMS).
This research provides fresh insights into the state of quality and compliance management in the Life Sciences industry, as well as quantitative data which demonstrates that many Life Sciences companies are preparing for or embracing Next-Generation Quality Management practices.
What does a Next-Generation Quality Management System (QMS) look like for a Life Sciences organization? Six Key Imperatives for Next-Generation Quality Management were identified:
Some organizations have made strides in each of these areas, while others are lagging behind. In many cases, the data shows that automated Enterprise Quality Management System (eQMS) has a positive impact on an organization’s ability to achieve desired results.
This e-book will help you benchmark your current quality management processes against these industry findings, and understand any gaps you may need to fill to stay ahead in the market. Click through to access the ebook by Pilgrim.